Further, MMP-8 has been widely nominated as a therapeutic target in AD [61,62], suggesting the ability of proteomic profiling at the extremes of a polygenic score distribution to uncover therapeutic targets. This evidence concerns the gene MMP8 and Alzheimer disease.